IZKS (Interdisciplinary Centre for Clinical Trials, German abb.: IZKS) is a professional academic clinical trial organisation at the University Medical Centre (UMC) Mainz. IZKS connects clinical trial activities in clinical trial units with non-clinical and methodological study activities. Success and achievements have been judged as very good in several evaluations reflecting high level of quality and efficiency of tasks taken over in clinical trials by IZKS.
1999 the University of Mainz started to develop a central clinical trial organisation by establishing the Coordinating Centre for Clinical Trials. Growing expertise and supply of services as well as increasing recognition led to the implementation and development of IZKS in 2007.
IZKS is funded by German Federal Ministry of Education and Research (BMBF) for continuous optimisation of multicentre clinical trials, for building regional trial networks and for improving qualification of study personnel. IZKS has established cooperations with academic and non-academic hospitals, private physicians, study groups, paediatric network (PAED-Net), surgical network (CHIR-Net), competence networks in medicine and with pharmaceutical and medical device industry. Success and achievements have been assessed repeatedly resulting in excellent appraisals and subsequently in funding extension and many new grants for research projects. In addition, quality and efficiency have been audited several times and GCP adherence has been confirmed by an inspection of the local authority. 70 trained and experienced medical, scientific and technical employees contribute to planning, conduct, evaluation and publication of clinical trials.
Extensive training programmes have been established for internal and external study staff.
Haupteingang der Universitätsmedizin Mainz
IZKS is successfully coordinating clinical and methodological study activities for more than four years now.
Full scope of clinical research according to ICH-GCP has been implemented with focus on conception, planning, conduct and analysis of innovative clinical trials investigating drugs, medical devices and other interventions, e.g. psychotherapeutic and surgical procedures.
IZKS offers efficient and quality-oriented conduct of clinical trials in 17 professional clinical trial units: Anaesthesia, Cardiology, Dermatology, Gynaecology, Gastroenterology, Hepatology/ Infectiology, Immunology/Haematology, Mental Disorders, Neurology, Oncology, Ophthalmology, Paediatrics, Pulmonology, Radiology and Rheumatology which provide a broad spectrum of methods and patients in 26 disease areas. IZKS is covering full service according to the requirements concerning sponsor responsibility in clinical trials, i.e.
IZKS is a partner of several German and European cooperations: IZKS is not only the regional trial centre of CHIR-Net but also a member of the competence network ‘Diabetes’ funded by German Federal Ministry of Education and Research (BMBF) and the Research Association ‘Musculoskeletal Diseases’ (Forschungsgemeinschaft Mukoviszidose e.V.). Additionally, IZKS is a partner of the Central European Society for Anticancer Drug Research (CESAR), the German Research Community for Cystic Fibrosis (German abb.: FGM) and the German Foundation for Organ Transplantation (German abb.: DSO).
Nationally and internationally, IZKS cooperates with trial centres of eighteen universities in Germany and five in other European countries as well as with universities and enterprises in the US.
IZKS offers certified courses and seminars for the qualification of scientific and non-scientific clinical research personnel. Furthermore inhouse-trainings and specific courses for various societies are performed as well as expert panels for clinical trials with medical devices.
The director of IZKS is authorized to train, educate and examine MDs who are aiming to acquire a board certification in clinical pharmacology.
Phone: 06131 17 99 13
Fax: 06131 17 99 14